Arbutus Biopharma Corporation (ABUS)
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in Arbutus Biopharma Corporation in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,347 for a total return of roughly -56.53%. All prices are adjusted for splits and dividends.
Compare to other instruments
Return
Arbutus Biopharma Corporation had a return of 31.33% year-to-date (YTD) and 5.88% in the last 12 months. Over the past 10 years, Arbutus Biopharma Corporation had an annualized return of -4.23%, while the S&P 500 had an annualized return of 9.76%, indicating that Arbutus Biopharma Corporation did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | 15.47% | 0.19% |
| Year-To-Date | 31.33% | 3.59% |
| 6 months | 59.38% | 7.70% |
| 1 year | 5.88% | -12.45% |
| 5 years (annualized) | -10.08% | 8.78% |
| 10 years (annualized) | -4.23% | 9.76% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 29.18% | -7.64% | ||||||||||
| 2022 | -13.96% | 22.51% | 0.43% | -0.85% |
Dividend History
Arbutus Biopharma Corporation doesn't pay dividends
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Arbutus Biopharma Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Arbutus Biopharma Corporation is 97.19%, recorded on Oct 9, 2019. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.19% | Mar 12, 2014 | 1406 | Oct 9, 2019 | — | — | — |
| -80.95% | Jan 20, 2011 | 213 | Nov 25, 2011 | 457 | Sep 26, 2013 | 670 |
| -36.08% | Nov 16, 2010 | 24 | Dec 20, 2010 | 20 | Jan 19, 2011 | 44 |
| -31.5% | Oct 8, 2013 | 46 | Dec 11, 2013 | 21 | Jan 13, 2014 | 67 |
| -18.01% | Feb 26, 2014 | 4 | Mar 3, 2014 | 2 | Mar 5, 2014 | 6 |
| -9.03% | Sep 27, 2013 | 2 | Sep 30, 2013 | 3 | Oct 3, 2013 | 5 |
| -7.7% | Jan 21, 2014 | 5 | Jan 27, 2014 | 3 | Jan 30, 2014 | 8 |
| -6.4% | Feb 21, 2014 | 1 | Feb 21, 2014 | 1 | Feb 24, 2014 | 2 |
| -6.09% | Feb 5, 2014 | 2 | Feb 6, 2014 | 3 | Feb 11, 2014 | 5 |
| -5.73% | Jan 14, 2014 | 1 | Jan 14, 2014 | 2 | Jan 16, 2014 | 3 |
Volatility Chart
Current Arbutus Biopharma Corporation volatility is 28.58%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.